BLI-489 hydrate

• 产品号: PZ0022
• CAS号: 623564-40-9(anhydrous)
• 分子式: C13H12N3NaO5S
• 分子量: 345.30625
• 纯 度: ≥98% (HPLC)

产品别名

• 标题: BLI-489 hydrate
• IUPAC标准名: sodium (5R)-6-{5H,6H,8H-imidazo[2,1-c][1,4]oxazin-3-ylmethylidene}-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate hydrate
• IUPAC传统名: sodium (5R)-6-{5H,6H,8H-imidazo[2,1-c][1,4]oxazin-3-ylmethylidene}-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate hydrate
• 别名: WAY-185489; 6-[(5,6-Dihydro-8H-imidazo[2,1-c][1,4]oxazin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium salt hydrate

产品登记号

• MDL号: MFCD22374169
• CAS号: 623564-40-9(anhydrous)

产品性质

• Empirical Formula (Hill Notation): C13H10N3NaO4S · xH2O
• 纯度: ≥98% (HPLC)
• 外观: powder, yellow
• 溶解度: H2O: >20 mg/mL
• 保存温度: room temp
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
BLI-489 is a penem β-lactamase inhibitor, which has shown activity against class A, C, and D β-lactamases. BLI-489 is being tested in combination therapy for drug-resistant bacteria.

详细说明 (简体中文)

Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
BLI-489 is a penem β-lactamase inhibitor, which has shown activity against class A, C, and D β-lactamases. BLI-489 is being tested in combination therapy for drug-resistant bacteria.